Clinical trial
Monoclonal Antibody Therapy or Biological Therapy in Treating Patients With…
NCT00004040 · Hoag Memorial Hospital Presbyterian, Other · Withdrawn
Key facts
| NCT number | NCT00004040 |
|---|---|
| Title | Monoclonal Antibody Therapy or Biological Therapy in Treating Patients With Chronic Lymphocytic Leukemia or Multiple Myeloma in Remission After Chemotherapy |
| Official title | Patients With Chronic Lymphocytic Leukemia or Multiple Myeloma Whose Disease Has Been Controlled With Chemotherapy: Rituximab Anti-CD20 Monoclonal Antibody or Interferon Alpha 2-b as Maintenance Therapy |
| Lead sponsor | Hoag Memorial Hospital Presbyterian, Other |
| Collaborators | Cancer Biotherapy Research Group |
| Status | Withdrawn |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Leukemia, Multiple Myeloma and Plasma Cell Neoplasm |
| Intervention type | Biological |
| Interventions | recombinant interferon alfa, rituximab |
| Enrollment | 0 |
| Start date | Jun 1, 1998 |
| Primary completion | Jun 1, 1999 |
| Completion | Jun 1, 1999 |
| First posted | Aug 5, 2004 |
| Last update posted | Aug 19, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: